Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.730
+0.170 (4.78%)
At close: Jun 26, 2026, 4:00 PM EDT
3.810
+0.080 (2.14%)
After-hours: Jun 26, 2026, 7:59 PM EDT

NRx Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-1.23----
Cost of Revenue
-0.51----
Gross Profit
-0.72----
Selling, General & Admin
13.9313.0613.514.2227.3174.94
Depreciation & Amortization Expenses
-0.070.01---
Research & Development
4.283.786.213.3717.0320.26
Other Operating Expenses
-0.060.04-1.20.25-22.14
Total Operating Expenses
18.1516.9418.527.8444.34117.34
Operating Income
-17.12-16.22-18.5-27.84-44.34-115.8
Interest Income
-0.01-0.01-0.04-0.49-0.25-
Interest Expense
-0.9-0.67-0.23-0.12--0.02
Other Non-Operating Income (Expense)
-6.5-22.48-6.44-2.694.3322.75
Total Non-Operating Income (Expense)
-7.41-23.16-6.71-3.34.0822.73
Pretax Income
-24.53-39.38-25.21-31.14-40.25-93.06
Net Income
-24.54-28.62-25.13-30.15-39.75-93.06
Net Income to Common
-24.54-28.62-25.13-30.16-39.75-348.89
Shares Outstanding (Basic)
252111875
Shares Outstanding (Diluted)
252111875
Shares Change (YoY)
102.29%101.06%40.50%15.20%40.17%36.90%
EPS (Basic)
-1.09-1.34-2.36-3.98-6.00-74.40
EPS (Diluted)
-1.09-1.34-2.36-3.98-6.00-74.40
Free Cash Flow
-14.93-14.11-10.64-21.66-39.77-37.71
Free Cash Flow Per Share
-0.59-0.66-1.00-2.86-6.05-8.04
Gross Margin
-58.78%----
Operating Margin
--1324.41%----
Profit Margin
--2336.49%----
FCF Margin
--1152.00%----
EBITDA
-16.99-16.08-18.5-27.83-44.33-115.79
EBITDA Margin
--1312.73%----
EBIT
-17.12-16.22-18.5-27.84-44.34-115.8
EBIT Margin
--1324.41%----
SEC Filings: 10-K · 10-Q